tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

HK:2162 Stock Latest News

Keymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
Company AnnouncementsKeymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
16d ago
2162
Keymed Biosciences Licenses CM355 to Prolium for Global Development
PremiumCompany Announcements
Keymed Biosciences Licenses CM355 to Prolium for Global Development
1M ago
2162
Keymed Biosciences Secures Licensing Deal for CM313
PremiumCompany Announcements
Keymed Biosciences Secures Licensing Deal for CM313
1M ago
2162
Keymed Biosciences Gains NMPA Approval for Stapokibart
PremiumCompany Announcements
Keymed Biosciences Gains NMPA Approval for Stapokibart
2M ago
2162
Keymed Biosciences Relocates Hong Kong Headquarters
PremiumCompany Announcements
Keymed Biosciences Relocates Hong Kong Headquarters
2M ago
2162
Keymed Biosciences’ CM336 Shows Promise in Myeloma Study
PremiumCompany AnnouncementsKeymed Biosciences’ CM336 Shows Promise in Myeloma Study
3M ago
2162
Keymed Biosciences Expands Global Reach with CM336 Deal
Premium
Company Announcements
Keymed Biosciences Expands Global Reach with CM336 Deal
3M ago
2162
Keymed Biosciences’ Stapokibart Wins Approval in China
Premium
Company Announcements
Keymed Biosciences’ Stapokibart Wins Approval in China
5M ago
2162
Keymed Biosciences Faces Steep Revenue Decline
PremiumCompany Announcements
Keymed Biosciences Faces Steep Revenue Decline
6M ago
2162
Keymed Biosciences Schedules Crucial Financial Meeting
PremiumCompany Announcements
Keymed Biosciences Schedules Crucial Financial Meeting
6M ago
2162
Keymed Biosciences Strikes Global Licensing Deal
PremiumCompany Announcements
Keymed Biosciences Strikes Global Licensing Deal
8M ago
2162
Keymed Biosciences Shareholders Back All Resolutions
PremiumCompany Announcements
Keymed Biosciences Shareholders Back All Resolutions
8M ago
2162
Keymed Biosciences Reveals Promising CM313 Study
PremiumCompany AnnouncementsKeymed Biosciences Reveals Promising CM313 Study
8M ago
2162
Keymed’s Stapokibart Drug Advances with Priority Review
Premium
Company Announcements
Keymed’s Stapokibart Drug Advances with Priority Review
9M ago
2162
Keymed Announces Positive Stapokibart Trial Results
Premium
Company Announcements
Keymed Announces Positive Stapokibart Trial Results
9M ago
2162
Keymed Reports Promising Cancer Drug Results
PremiumCompany Announcements
Keymed Reports Promising Cancer Drug Results
9M ago
2162
Keymed Biosciences’ Stapokibart Gains Priority Review
PremiumCompany Announcements
Keymed Biosciences’ Stapokibart Gains Priority Review
9M ago
2162

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >